12:00 AM
 | 
Jan 02, 2012
 |  BC Week In Review  |  Financial News  |  Other Financial News

Coronado Biosciences financial update

Coronado Biosciences listed on NASDAQ through the Form 10 pathway. The company, which listed...

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >